Table IV.
Assessment of liver function.
| Parameter | Patient no. |
|---|---|
| Total bilirubin, umol/l | |
| Median (IQR) | 12.95 (10.27-16.92) |
| <5.1 (%) | 1/78 (1.3) |
| >19.0 (%) | 14/78 (17.9) |
| Direct bilirubin, µmol/l | |
| Median (IQR) | 4.0 (3.3-5.0) |
| <1.7 (%) | 0/78 (0) |
| >6.8 (%) | 7/78 (9.0) |
| Total protein, g/l | |
| Median (IQR) | 64.9 (61.82-67.32) |
| <64 (%) | 36/78 (46.2) |
| >83(%) | 0/78 (0) |
| Albumin, g/l | |
| Median (IQR) | 36.75 (33.08-40.25) |
| <35 (%) | 27/78 (34.6) |
| >55 (%) | 0/78 (0) |
| Globulin, g/l | |
| Median (IQR) | 27.3 (24.98-30.43) |
| <20 (%) | 2/78 (2.6) |
| >30 (%) | 21/78 (26.9) |
| Alanine aminotransferase, IU/l | |
| Median (IQR) | 27 (20-37.25) |
| <8 (%) | 0/78 (0) |
| >40 (%) | 14/78 (17.9) |
| Aspartate aminotransferase, IU/l | |
| Median (IQR) | 25.5 (17.75-48) |
| <5 (%) | 0/78 (0) |
| >35 (%) | 29/78 (37.2) |
| Alkaline phosphatase, IU/l | |
| Median (IQR) | 78 (67-99.25) |
| <40 (%) | 0/78 (0) |
| >150 (%) | 1/78 (1.3) |
| γ-Glutamyltranspeptidase, IU/l | |
| Median (IQR) | 28.5 (19-48.5) |
| <7 (%) | 0/78 (0) |
| >32 (%) | 34/78 (43.6) |
IQR, interquartile range.